Background: There has been increasing use of mobile mHealth applications, including pain assessment and pain self-management apps. The usability of mHealth applications has vital importance as it affects the quality of apps. Thus, usability assessment with methodological rigor is essential to minimize errors and undesirable consequences, as well as to increase user acceptance.
Objective: this study aimed to synthesize and evaluate existing studies on the assessment of the usability of pain-related apps using a newly developed scale.
Methods: an electronic search was conducted in several databases, combining relevant keywords. Then titles and abstracts were screened against inclusion and exclusion criteria. The eligible studies were retrieved and independently screened for inclusion by two authors. Disagreements were resolved by discussion until consensus was reached.
Results: a total of 31 articles were eligible for inclusion. Quality assessment revealed that most manuscripts did not assess usability using valid instruments or triangulation of methods of usability assessment. Most manuscripts also failed to assess the three domains of usability (effectiveness, efficiency and satisfaction).
Conclusions: future studies should consider existing guidelines on usability assessment design, development and assessment of pain-related apps.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038093 | PMC |
| http://dx.doi.org/10.3390/ijerph17030785 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Many outcome measures used in AD clinical trials require clinic visits and are paper based, making them infrequent and burdensome 'snapshots', subject to rater bias. A consortium of 10 pharma companies came together with Cumulus Neuroscience to design a solution for frequent, objective, real-world measurement across a range of domains. We present a study that examined the feasibility of asking patients with mild dementia to use the neuroassessment platform repeatedly at home for one year.
View Article and Find Full Text PDFPublic Health.
Alzheimers Dement
December 2024
Boston University School of Public Health, Boston, MA, USA.
Background: Global health is increasingly burdened by oral diseases (ODs) affecting 3.9 billion people, and Alzheimer's disease with related dementias (AD/ADRD), impacting 46.8 million globally.
View Article and Find Full Text PDFBackground: In 2020, five Italian scientific societies issued diagnostic recommendations to improve the rational and combined use of biomarkers in the clinical practice of Italian memory clinics (Boccardi et al., 2020). The present project will aim to compare the most frequent diagnostic workups in three academic memory clinics before (pre-recommendations: January 2018 - December 2019) and after (post-recommendations: October 2022 - October 2023) the release of the recommendations to assess their implementation in clinical routine.
View Article and Find Full Text PDFBackground: Persons with dementia often lose decisional capacity before death, underscoring the need for dementia-focused advance care planning tools. We created LEAD (Life-Planning in Early Alzheimer's and Other Dementias). This intervention guides patients with early-stage dementia and their care partners through conversations to identify and discuss the patient's values and preferences for end-of-life care.
View Article and Find Full Text PDFDeveloping Topics.
Alzheimers Dement
December 2024
Roche Pharma AG, Grenzach-Wyhlen, Baden-Württemberg, Germany.
Background: The timely diagnosis of mild cognitive impairment (MCI) in Alzheimer's disease is challenging in routine care due to the complexity and time burden of required cognitive assessments. New unsupervised digital remote assessment tools could adress this challenge.
Method: The multicentric healthcare study "re.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!